Vanishing white matter disease

Marjo S van der Knaap1, Jan C Pronk, Gert C Scheper

  • 1Department of Pediatrics and Child Neurology, VU University Medical Center, Amsterdam, Netherlands. ms.vanderknaap@vumc.nl

The Lancet. Neurology
|April 25, 2006
PubMed

Insights

Vanishing white matter disease (VWM), a common childhood neurological disorder, stems from defects in the protein synthesis factor eIF2B. This leads to progressive white matter loss, particularly affecting glial cells.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Vanishing white matter disease (VWM) is a prevalent inherited childhood leucoencephalopathy.
  • It presents with chronic neurological deterioration, often starting in early childhood and characterized by cerebellar ataxia.
  • VWM exhibits unique sensitivity to stressors like infections and trauma, potentially causing rapid decline and coma.

Purpose of the Study:

  • To elucidate the underlying genetic defects and cellular mechanisms in Vanishing White Matter Disease.
  • To understand the selective vulnerability of glial cells in VWM despite defects in a housekeeping gene.
  • To explore the role of the unfolded-protein response in VWM pathophysiology.

Main Methods:

  • Review of clinical phenotypes and diagnostic MRI findings in VWM patients.
  • Analysis of the genetic basis involving subunits of eukaryotic translation initiation factor eIF2B.
  • Investigation into the cellular impact on oligodendrocytes and astrocytes, and the unfolded-protein response.

Main Results:

  • VWM is caused by mutations in genes encoding subunits of the eIF2B factor, crucial for protein synthesis.
  • MRI scans are diagnostic, showing characteristic vanishing of cerebral white matter.
  • Despite eIF2B being essential in all cells, oligodendrocytes and astrocytes are disproportionately affected.

Conclusions:

  • Defects in eIF2B lead to Vanishing White Matter Disease, a severe leukoencephalopathy.
  • The selective vulnerability of glial cells in VWM remains incompletely understood.
  • Further research into the unfolded-protein response is critical for understanding VWM pathogenesis.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Prosopagnosia01:24

Prosopagnosia

Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...